Today is the last day of one of the world´s most important pharma events – DCATWeek in New York City!

Our Tiefenbacher Group team sends greetings and their impressions of DCAT Week from the Big Apple! These were very successful days for Tiefenbacher Group. During these days we presented our latest product portfolio and innovations to our existing and potential new partners at the DCAT Week in New York City. We love the inspiring atmosphere here and look forward to exciting encounters and interesting discussions on this final day.

DCAT Week is the premier global event held annually in New York City. Especially for companies engaged in the Bio/Pharmaceutical Manufacturing Value Chain this event is important. Generally it is hosted by the Drug, Chemical & Associated Technologies Association (DCAT). Emphasising that it is a not-for-profit, member-supported, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies.

About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at or visit us on: